2 598

Cited 0 times in

Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction.

Authors
 Hun Lee  ;  Kyung Min  ;  Eung Kweon Kim  ;  Tae-Im Kim 
Citation
 AMERICAN JOURNAL OF OPHTHALMOLOGY, Vol.154(6) : 949-957, 2012 
Journal Title
AMERICAN JOURNAL OF OPHTHALMOLOGY
ISSN
 0002-9394 
Issue Date
2012
MeSH
Administration, Oral ; Aged ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/therapeutic use* ; Cytokines/metabolism* ; Eye Proteins/metabolism* ; Eyelid Diseases/drug therapy* ; Eyelid Diseases/metabolism ; Female ; Flow Cytometry ; Fluorophotometry ; Humans ; Luminescent Measurements ; Male ; Meibomian Glands/drug effects* ; Meibomian Glands/metabolism ; Middle Aged ; Minocycline/administration & dosage ; Minocycline/therapeutic use* ; Ophthalmic Solutions/administration & dosage ; Prospective Studies ; Tears/metabolism* ; Treatment Outcome
Keywords
Administration, Oral ; Aged ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/therapeutic use* ; Cytokines/metabolism* ; Eye Proteins/metabolism* ; Eyelid Diseases/drug therapy* ; Eyelid Diseases/metabolism ; Female ; Flow Cytometry ; Fluorophotometry ; Humans ; Luminescent Measurements ; Male ; Meibomian Glands/drug effects* ; Meibomian Glands/metabolism ; Middle Aged ; Minocycline/administration & dosage ; Minocycline/therapeutic use* ; Ophthalmic Solutions/administration & dosage ; Prospective Studies ; Tears/metabolism* ; Treatment Outcome
Abstract
PURPOSE: To assess clinical outcomes and tear cytokine levels in patients with moderate and severe meibomian gland dysfunction (MGD) after treatment with oral minocycline and artificial tears versus artificial tears only.
DESIGN: Prospective, randomized clinical trial.
METHODS: Sixty eyes of 60 patients with stage 3 or 4 meibomian gland dysfunction were enrolled. We evaluated the tear film break-up time, Schirmer test results, corneal and conjunctival fluorescein staining results, biomicroscopic examination results of lid margins and meibomian glands, and tear cytokine levels before and after 1 month and 2 months of oral minocycline and artificial tears (group 1) or artificial tears only (group 2). Tear samples were collected and analyzed using a BD Cytometric Bead Array (BD Bioscience, San Jose, California, USA) for detection of interleukin (IL)-1β, IL-6, IL-7, IL-8, IL-12p70, IL-17α, interferon-γ, tumor necrosis factor-α, and monocyte chemotactic protein-1. The Wilcoxon signed-rank test, Mann-Whitney U test, generalized linear model, and linear mixed model were performed.
RESULTS: Patients in group 1 showed statistically significant improvement in all clinical signs and symptoms after 1 month and 2 months of treatment. Patients of group 1 showed more significant improvement compared with those in group 2. Patients in group 1 also showed statistically significant reductions in IL-6, IL-1β, IL-17α, tumor necrosis factor-α, and IL-12p70 after 2 months of treatment.
CONCLUSIONS: Oral minocycline can provide clinical benefits in treating moderate and severe meibomian gland dysfunction by reducing inflammatory cytokine levels.
Full Text
http://www.sciencedirect.com/science/article/pii/S0002939412004400
DOI
22967863
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Ophthalmology (안과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers
Yonsei Authors
Kim, Eung Kweon(김응권) ORCID logo https://orcid.org/0000-0002-1453-8042
Kim, Tae-Im(김태임) ORCID logo https://orcid.org/0000-0001-6414-3842
Min, Kyung(민경)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/89433
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links